STIMCONEConus Medullaris Stimulation With 5 Columns Lead Versus Medical Treatment in Refractory Pudendal Neuralgia: a Randomized, Open, Controlled, Multicenter Trial.
CMS group
+ OMM group
Síndromes de Compresión del Nervio+6
+ Enfermedades del sistema nervioso
+ Neuralgia
Estudio de Tratamiento
Resumen
Fecha de inicio: 30 de septiembre de 2015
Fecha en la que se inscribió al primer participante.In this national multicenter prospective open label trial, patients will be randomized 1:1 to experimental group (CMS group : Conus Medullaris Stimulation using pentapolar surgical lead, plus optimal medical management) or to control group (OMM group : optimal medical management alone) and followed for 12 months, in intention to treat. 42 patients suffering of refractory pudendal neuralgia will be included. Optimal medical management will be prescribed by algologists in both groups according to patient pain relief.
Protocolo
Esta sección proporciona detalles del plan del estudio, incluyendo cómo está diseñado y qué se está evaluando.Se reclutarán 42 pacientes
Número total de participantes que el ensayo clínico espera reclutar.Estudio de Tratamiento
Elegibilidad
Los investigadores buscan pacientes que cumplan ciertos criterios, conocidos como criterios de elegibilidad: estado general de salud o tratamientos previos.Cualquier sexo
Sexo biológico de los participantes elegibles para inscribirse.A partir de 18 años
Rango de edades de los participantes que pueden unirse al estudio.Voluntarios sanos no permitidos
Indica si personas sanas, sin la condición que se estudia, pueden participar.Condiciones
Patología
Criterios
PRE-SCREENING CRITERIA: * Male or female aged 18 years or over * Pudendal neuralgia according published Nantes criteria * History of failure medical management : defined by HAS such as intractable pain after failure (by side effect, ineffective, or contraindication) at effective dose and combination of following treatment: * Pain treatment OMS analgesics Level I or II * Tricyclicantidepressant * Antiepileptics * Nerve block * Muscle relaxants * Physiotherapy * TENS (Transcutaneus electric nerve stimulation) * Psychobehavioral approach * Failure of pudendal nerve decompression surgery performed more than 12 months ago * Neuropathic pain according to criteria of the Neuropathic Pain Diagnostic Questionnaire (DN4). * Subjects able of giving informed consent * Affiliation with French social security system. * Average or maximum pain experienced greater than or equal to 5/10 on a visual analogue scale INCLUSION CRITERIA: * Average or maximum pain experienced greater than or equal to 50/100 on a visual analogue scale (average of data collected 7 days prior to the inclusion visit and recorded by the patient on the clinical diary) * Evaluation by multidisciplinary team including neuro-surgeons, algologists and psychologists performed, (if not already done in the previous year for algologists and psychologists) * Given informed consent. EXCLUSION CRITERIA: * Pregnant, or planning to become pregnant during the study (12months) * Adults under guardianship or trusteeship * Being treated or has been treated with spinal cord stimulation, subcutaneous or peripheral nerve stimulation, intrathecal drug delivery system. * Had pudendal nerve decompression surgery less than 12 months ago * Is suspected of substance abuse * Has unresolved major issues of secondary gain * Exhibits major psychiatric morbidity * Has life expectancy inferior to 5 years * Implant spinal cord stimulation surgery contraindication : * Magnetic resonnance imaging contraindication * History of coagulation disorder * Severe immunodepression, systemic, due to medicine drug intake or not (AIDS, transplanted, under anti TNF alpha treatment, …) * Current infection * Would be unable to operate the spinal cord stimulation equipment, undergo the study assessments or complete questionnaires or clinical diary, based on the opinion of the investigator * Unwilling to be treated with spinal cord stimulation, comply with study requirements. * Suffering from another neuropathic pain, or chronic pain, cancer, diabetic neuropathy * Patient with cardiac sentry stimulator or planned to be implanted with one
Plan de Estudio
Conoce todos los tratamientos administrados en este estudio, su descripción detallada y en qué consisten.2 grupos de intervención están designados en este estudio
0% de probabilidad de ser asignado al grupo placebo
Grupos de Tratamiento
Grupo I
ExperimentalGrupo II
Comparador ActivoObjetivos del Estudio
Objetivos Primarios
Objetivos Secundarios
Centros del Estudio
Estos son los hospitales, clínicas o centros de investigación donde se lleva a cabo el estudio. Puedes encontrar la ubicación más cercana a ti y su estado de reclutamiento.Este estudio tiene 7 ubicaciones
Clinic Catherine de Sienne
Nantes, FranceHôpital Foch
Suresnes, FranceLille University Hospital
Lille, France